Novel KIR‑CAR T Approach Shows Early Activity Against Solid Tumors
Early results presented at AACR show that a novel KIR‑CAR T therapy demonstrates safety and efficacy in solid tumors, pointing to a new strategy for addressing T cell exhaustion and broadening the reach of cell therapy beyond hematologic cancers. The post Novel KIR‑CAR T Approach Shows Early Activity Against Solid Tumors appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.